Thr17
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.7
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr17  -  PLB (dog)

Site Information
SAIRRAstIEMPQQA   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 448115

In vivo Characterization
Methods used to characterize site in vivo:
phospho-antibody ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:
heart ( 1 )

Upstream Regulation
Kinases, in vitro:
CAMK2A (human) ( 2 , 3 ) , PKACA (dog) ( 2 )
Treatments:
heart failure ( 1 )

References 

1

Mishra S, Sabbah HN, Jain JC, Gupta RC (2003) Reduced Ca2+-calmodulin-dependent protein kinase activity and expression in LV myocardium of dogs with heart failure. Am J Physiol Heart Circ Physiol 284, H876-83
12424092   Curated Info

2

Mayer EJ, Huckle W, Johnson RG, McKenna E (2000) Characterization and quantitation of phospholamban and its phosphorylation state using antibodies. Biochem Biophys Res Commun 267, 40-8
10623571   Curated Info

3

Simmerman HK, et al. (1986) Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. J Biol Chem 261, 13333-41
3759968   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2024 Cell Signaling Technology, Inc.